◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Legence Corp. Class A Common stock (LGN) EBITDA 2022–TTM

Name: Legence Corp. Class A Common stock (LGN) ebitda history 2022-TTM
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

DATA UPDATED 2026-09-19

Legence Corp. Class A Common stock annual ebitda for fiscal 2025 was $161 million, an increase of 2.5% from $157 million in fiscal 2024. All figures are reported results from public filings — no estimates or projections.

LGN Annual EBITDA

EBITDA (annual)	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31
EBITDA	—	$161M	$157M	$107M	$69M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

LGN Quarterly EBITDA

EBITDA (quarterly)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
EBITDA	—	$58M	($4M)	$60M	$61M	$44M	—	—	$57M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

EBITDA at Comparable Companies

MTZ EBITDA — MasTec Inc
APG EBITDA — Api Group Corp
STRL EBITDA — Sterling Infrastructure, Inc.
IESC EBITDA — IES Holdings Inc
DY EBITDA — Dycom Industries Inc
ACM EBITDA — Aecom Technology Corporation

More LGN metrics: Revenue · Gross Profit · Operating Income · Net Income · EPS · Free Cash Flow · Shares Outstanding

All LGN financial statements → Interactive LGN charts →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.